trending Market Intelligence /marketintelligence/en/news-insights/trending/chqsr0dUjGTPCCpgqpXSeg2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

Bionano Genomics to raise $41.5M through loans, share sale

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Street Talk - Ep. 64: Coronavirus jumpstarts digital adoption

Street Talk Podcast

Street Talk - Ep. 63: Deal talks continue amid bank M&A freeze, setting up for strong Q4

Street Talk Podcast

Street Talk - Ep. 62: 'Brutal' outlook for oil demand offers banks in oil patch no relief

Bionano Genomics to raise $41.5M through loans, share sale

Bionano Genomics Inc. will raise $41.5 million through loans and equity sale involving Innovatus Capital Partners LLC, East West Bancorp Inc. and Aspire Capital Fund LLC.

The San Diego-based company entered into a loan and security agreement with Innovatus Capital to raise about $25 million in loans, with $20 million available on or about March 22, and the remainder dependent on meeting financial goals.

California's East West Bank will offer Bionano a revolving line of credit of as much as $5 million.

Innovatus Capital, a New York-based asset management firm, also agreed to buy the genome mapping company's 406,504 common shares for $1.5 million.

Further, Chicago-based Aspire Capital agreed to buy up to $10 million worth of equity in the company, with an initial purchase of 272,479 common shares for $1 million. Aspire Capital may buy up to $9 million of additional company common shares over a 30-month period at the prevailing market share prices.

The financing will enable the company to advance its global sales strategy and the adoption of its genome analysis platform, the Saphyr system, Bionano CEO Erik Holmlin said in a statement.